ExploraMed

Revelle Aesthetics is a company focused on developing innovative medical devices tailored to address women's aesthetic concerns, particularly in the area of cellulite. Founded from ExploraMed, a prominent medtech incubator, Revelle Aesthetics is driven by a team of dedicated professionals from the medical device and aesthetics sectors. The company aims to provide effective solutions that enable practitioners to achieve reliable outcomes while delivering meaningful results for women seeking to enhance their appearance.

Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.

Nuelle is a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women. It marries its experience in healthcare solutions, consumer products, and technology with a deep understanding of women’s unfulfilled needs. From inception, Nuelle has taken a holistic view of these needs and desires. They worked closely with thought leaders and experts in women’s sexual medicine and wellness including physicians, sex therapists, physical therapists, and psychologists. Together we developed insights that allow Nuelle to translate its scientific approach to understanding.

Vibrynt operates in the medical device sector and offers a system designed to assist with weight loss by limiting food consumption.

Moximed, Inc. is a medical technology company based in Hayward, California, that focuses on developing innovative treatments for patients with knee osteoarthritis. The company offers the Atlas System, an implantable joint unloader designed to alleviate pain associated with medial compartment knee osteoarthritis, allowing patients to maintain high levels of activity. Additionally, Moximed has developed the MISHA Knee System, which provides an outpatient treatment option for individuals who have not responded to conventional therapies and are not suitable candidates for knee replacement surgery. By minimizing joint pain and providing dynamic load reduction, Moximed's implants aim to improve the standard of care and enhance the quality of life for patients, potentially delaying or avoiding the need for more invasive surgical interventions. Moximed has been operational since its incorporation in 2006, serving patients and medical professionals globally.

NeoTract, Inc. is a medical device company specializing in the development and manufacture of minimally invasive surgical devices for urological disorders. Founded in 2004 and headquartered in Pleasanton, California, NeoTract focuses on the UroLift system, which is designed to treat men with enlarged prostates while preserving normal sexual function. The company serves a diverse customer base across the United States, Europe, Australia, Canada, Mexico, and South Korea. As a subsidiary of Teleflex Urology Limited, NeoTract aims to address critical needs in the urology field through innovative clinical solutions.

Acclarent, Inc. is a medical device company focused on developing innovative technologies for ear, nose, and throat (ENT) patients. The company specializes in balloon sinuplasty devices, which are minimally invasive tools designed to assist physicians in treating chronic sinusitis. These devices enable doctors to navigate sinus anatomy effectively, facilitating the opening of blocked sinus ostia and passageways to promote proper sinus drainage. Acclarent's Balloon Sinuplasty technology and associated Relieva product portfolio provide alternatives to traditional endoscopic surgical methods. The company's devices received FDA clearance and were commercially launched in the United States in 2005, marking a significant advancement in the treatment options available for patients with sinus-related conditions.